文献速递血栓与止血

非重型血友病患者的出血表型

The bleeding phenotype in people with nonsevere hemophilia.
PubMed 文献 · Blood Adv · 2022-01-01

DYNAMO 国际多中心队列纳入 304 例 12 至 55 岁非重型血友病男性(FVIII/IX 0.02-0.35 IU/mL),从病历收集首次治疗出血、年出血率(ABR)与年关节出血率(AJBR)。中位 ABR 0.2、AJBR 0.0,但 51% 曾发生关节出血;基线 FVIII/IX 与关节出血率呈负相关(P < .001)。

要点

  • 304 例非重型血友病患者中 245 例(81%)至少发生 1 次出血,156 例(51%)至少发生 1 次关节出血。
  • 中位 ABR 0.2(IQR 0.1-0.5),中位 AJBR 0.0(IQR 0.0-0.2)。
  • 基线 FVIII/IX 与关节出血率呈负相关(P < .001)。

核心结论

  • 非重型血友病患者出血率低,但半数青少年和成人曾发生关节出血。
  • 基线 FVIII/IX 水平与关节出血率呈负相关(P < .001)。

研究设计与样本

  • DYNAMO 研究为国际多中心队列,纳入 304 例 12 至 55 岁男性非重型血友病(FVIII/IX 0.02-0.35 IU/mL)患者,其中中型 70 例、轻型 234 例。
  • 从病历收集首次治疗(关节)出血年龄、年出血率(ABR)与年关节出血率(AJBR)。
  • 采用复发事件 frailty 模型评估基线 FVIII/IX 水平与关节出血率的关联。

主要发现

  • 中位年龄 38 岁(IQR 25-49 岁),中位基线 FVIII/IX 水平 0.12 IU/mL(IQR 0.05-0.21 IU/mL)。
  • 245 例(81%)至少发生 1 次出血,156 例(51%)至少发生 1 次关节出血;首次出血和首次关节出血的中位年龄分别为 8 岁和 10 岁。
  • 中位 ABR 为 0.2(IQR 0.1-0.5),中位 AJBR 为 0.0(IQR 0.0-0.2)。
  • 基线 FVIII/IX 从 0.02-0.05 IU/mL 至 >0.25 IU/mL,中位 ABR 从 0.6(IQR 0.2-1.4)降至 0.1(IQR 0.0-0.2),中位 AJBR 从 0.2(IQR 0.0-0.4)降至 0.0(IQR 0.0-0.0)。
  • 基线 FVIII/IX 与关节出血率呈负相关(P < .001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Detailed information on the onset, frequency, and severity of bleeding in nonsevere hemophilia is limited. We aimed to assess the bleeding phenotype of persons with nonsevere hemophilia and to analyze the association between baseline factor VIII/IX (FVIII/IX) levels and the joint bleeding rate. In the DYNAMO (Dynamic Interplay Between Bleeding Phenotype and Baseline Factor Level in Moderate and Mild Hemophilia A and B) study, an international multicenter cohort, we included males with nonsevere hemophilia (FVIII/IX, 0.02-0.35 IU/mL) aged 12 to 55 years. Information on age at first treated (joint) bleed, annual bleeding rates (ABRs), and annual joint bleeding rates (AJBRs) was collected from the medical files. The association between baseline FVIII/IX levels and the joint bleeding rate was assessed by using a frailty model for recurrent events. In total, 304 persons (70 with moderate hemophilia and 234 with mild hemophilia) were included. The median age was 38 years (interquartile range [IQR], 25-49 years), and the median baseline FVIII/IX level was 0.12 IU/mL (IQR, 0.05-0.21 IU/mL). In total, 245 (81%) persons had experienced at least 1 bleed, and 156 (51%) had experienced at least 1 joint bleed. The median age at first bleed and first joint bleed was 8 and 10 years, respectively. The median ABR and AJBR was 0.2 (IQR, 0.1-0.5) and 0.0 (IQR, 0.0-0.2). From baseline FVIII/IX levels 0.02 to 0.05 IU/mL to >0.25 IU/mL, the median ABR decreased from 0.6 (IQR, 0.2-1.4) to 0.1 (IQR, 0.0-0.2) and the AJBR from 0.2 (IQR, 0.0-0.4) to 0.0 (IQR, 0.0-0.0). Baseline FVIII/IX was inversely associated with the joint bleeding rate (P < .001). Low bleeding rates were observed in persons with nonsevere hemophilia. However, one-half of all adolescents and adults had experienced a joint bleed.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Kloosterman FR, Zwagemaker AF, Bagot CN, et al. The bleeding phenotype in people with nonsevere hemophilia. Blood Adv. 2022. PMID: 35533261. doi:10.1182/bloodadvances.2022007620

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。